DBD vs EVCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

DBD

50.0
AI Score
VS
DBD Wins

EVCM

45.1
AI Score

Investment Advisor Scores

DBD

50score
Recommendation
HOLD

EVCM

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DBD EVCM Winner
Forward P/E 12.1655 11.0742 EVCM
PEG Ratio 0 0.3691 Tie
Revenue Growth 1.7% 2.7% EVCM
Earnings Growth 34.2% 16.3% DBD
Tradestie Score 50.0/100 45.1/100 DBD
Profit Margin 2.9% 5.7% EVCM
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

DBD 1M: -5.2% · 3M: -24.0% EVCM 1M: +22.6% · 3M: -0.9%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.6%), weak momentum, RSI 42

RSI (14): 41.9 · Price: $63.18

EVCM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 65.9 · Price: $9.89

Fundamentals Snapshot

Metric DBD EVCM
Market Cap — —
Forward P/E 9.0 12.5
Trailing P/E 20.3 54.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.8%
Operating Margin 0.1% 0.1%
EPS 3.02 0.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.